Point of care respiratory viral testing (POCT): A novel service to target appropriate antimicrobial prescription and improve antibiotic stewardship.

K. Roy (Watford, United Kingdom), K. Groom (Watford, United Kingdom), M. Knight (Watford, United Kingdom)

Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Session: Improving the outcomes of community-acquired pneumonia
Session type: Poster Discussion
Number: 2032
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Roy (Watford, United Kingdom), K. Groom (Watford, United Kingdom), M. Knight (Watford, United Kingdom). Point of care respiratory viral testing (POCT): A novel service to target appropriate antimicrobial prescription and improve antibiotic stewardship.. 2032

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Rational use and stewardship of antibiotics in pediatric respiratory disease
Source: ERS Courses: Paediatric respiratory infections
Year: 2019


Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance
Source: Eur Respir J 2012; 39: 802-804
Year: 2012


Prescribing and guidelines: both must improve to combat antimicrobial resistance
Source: Eur Respir J 2011; 37: 9-11
Year: 2011


Prescribing and guidelines: both must improve to combat antimicrobial resistance
Source: Eur Respir J 2012; 39: 1050
Year: 2012


The importance of long-term rational antibiotic use educational and control programmes among general practitioners
Source: Annual Congress 2009 - Medical education
Year: 2009


Respiratory viral point of care testing (POCT) allows improved infection control and bed management  during an influenza outbreak
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018


Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation
Source: Eur Respir J 2014; 44: 1412-1417
Year: 2014


Improving the appropriate use of Mannitol challenge testing in a large teaching hospital.
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021


How to link antimicrobial and diagnostic stewardship
Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship
Year: 2019


An audit of adherence to antituberculous drugs using a new, rapid, point of care test for isoniazid metabolites
Source: Eur Respir J 2002; 20: Suppl. 38, 566s
Year: 2002

How to build an antimicrobial stewardship programme
Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship
Year: 2019


Antibiotic stewardship in the hospital setting
Source: Eur Respir Monogr 2017; 75: 127-149
Year: 2017


WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Source: Eur Respir J 2011; 38: 516-528
Year: 2011



Antibiotic use and misuse in the community: how to manage the problem
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006



Pattern of antibiotic resistance in hospital acquired pneumonia in a country where antibiotics are available over the counter without doctors prescription
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities
Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020
Year: 2021



A clinical and aetiological evaluation of community acquired pneumonia-are we following guidelines in prescribing antibiotics?
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice.
Source: International Congress 2017 – COPD management
Year: 2017

Clinical effectiveness of recommended antibiotics in COVID19 pneumonias; assessing national referral centre guidance
Source: Virtual Congress 2021 – COVID - 19 treatments
Year: 2021


The impact of national recommendations on antibiotic treatment of community acquired pneumonia. Do pediatricians follow the national guidelines?
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017